Join StocksJar.com -Get 7 Days Free trial

Medtronic (MDT) Stock Price & AI Analysis

NYSE
USA

$88.38

$0.30
(0.34%)

Subscribe to get
AI Score

  • Market Cap 113.33B
  • Volume 8.38M
  • Avg Volume 6.57M
  • Target Price $94.04
  • 52W Range 75.96 - 92.68
  • RSI (14) 69.12
  • Beta 0.85
  • PEG Ratio 4.32
  • SMA 20 7.38
  • SMA 50 5.06
  • SMA 200 5.01
  • Insider Owner 0.07%
  • Insider Trans -1.09%
  • Institution Owner 84.57%
  • Institution Trans -0.89%
  • Short Interest 9.81%
  • EPS next Y 7.16

Medtronic Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic | Latest news

Is Medtronic plc (MDT) the Best Halal Dividend Stock to Invest In Now?

Is Medtronic plc (MDT) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we...

Insider Monkey - 3 hours ago

Is Medtronic plc (MDT) the Best Stock to Invest In For Steady Dividends?

Is Medtronic plc (MDT) the Best Stock to Invest In For Steady Dividends?

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we...

Insider Monkey - 1 day ago

Jim Cramer on Medtronic plc (MDT) CEO Geoffrey S. Martha: ‘I Remembered What He...

Jim Cramer on Medtronic plc (MDT) CEO Geoffrey S. Martha: ‘I Remembered What He...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to...

Insider Monkey - 2 days ago

Jim Cramer on Medtronic plc (MDT): ‘They’re Going To Have Mid Single Digit...

Jim Cramer on Medtronic plc (MDT): ‘They’re Going To Have Mid Single Digit...

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California...

Insider Monkey - 3 days ago

Medtronic plc (MDT): Strong Revenue Growth and AI-Driven Innovations...

Medtronic plc (MDT): Strong Revenue Growth and AI-Driven Innovations...

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are...

Insider Monkey - 5 days ago

SeaCrest Wealth Management LLC Has $636,000 Stock Holdings in Medtronic plc...

SeaCrest Wealth Management LLC Has $636,000 Stock Holdings in Medtronic plc...

SeaCrest Wealth Management LLC lifted its position in Medtronic plc (NYSE:MDT – Free Report) by 3.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and ...

ETF DAILY NEWS - 7 days ago

MDT to host open house on Highway 93 Missoula to Florence study

MDT to host open house on Highway 93 Missoula to Florence study

There will be two in-person open house meetings on Jan. 22 and Jan. 23 from 4 p.m. to 7 p.m. at Lolo...

NBC Montana - 5 days ago

MDT reports full blockage of S-540

MDT reports full blockage of S-540

Montana Department of Transportation is reporting a full blockage of S-540 at mile post 4, south of Livingston.Rocks are on the roadway, and it is...

NBC Montana - 4 days ago

Beta Bionics Targets $113 Million in IPO, Plans Nasdaq Listing

Beta Bionics Targets $113 Million in IPO, Plans Nasdaq Listing

The gadget finds insulin dosages using adaptive closed-loop algorithms, therefore eliminating human...

GuruFocuscom - 3 hours ago

TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?

TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?

GEHC and Abbott Laboratories ABT. MDT and GEHC shares have plunged 3.5% and 1.8%, respectively,...

Zacks - 5 hours ago